Canopy Growth CEO on cannabis sell-off thumbnail

Canopy Growth CEO on cannabis sell-off

Bruce Linton, Canopy Growth CEO, discusses the volatile moves in cannabis stocks just a week after Canada legalized recreational marijuana use.

Green Growth mulls takeover bid for Canadian cannabis company Aphria thumbnail

Green Growth mulls takeover bid for Canadian cannabis company Aphria

CNBC’s Aditi Roy discusses Green Growth’s takeover bid of Canadian cannabis company Aphria following the country’s legalization of marijuana this year. Subscribe to CNBC: About CNBC: From ‘Wall Street’ to…

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC thumbnail

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC

Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…

How illegal dispensaries are a threat to the legal cannabis industry thumbnail

How illegal dispensaries are a threat to the legal cannabis industry

The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…

US Officials could be ready to crack down on cannabis craze thumbnail

US Officials could be ready to crack down on cannabis craze

Are US border officials cracking down on the cannabis industry? Pot stocks get smoked. With CNBC’s Aditi Roy and Scott Wapner, and the Fast Money traders, Pete Najarian, Tim Seymour,…

How midterm elections could impact the cannabis business thumbnail

How midterm elections could impact the cannabis business

Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…

Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst thumbnail

Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst

CNBC’s “Squawk Alley” team talks about legislation that would legalize cannabis and what that means for cannabis companies with Vivien Azer, Cowen’s senior cannabis and beverage sector analyst.

Cannabis reclassification is 'a real milestone' for the industry," says Curaleaf's Boris Jordan thumbnail

Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan

Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.

Inside one of the biggest cannabis investor conferences thumbnail

Inside one of the biggest cannabis investor conferences

The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC thumbnail

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC

He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…